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Background: Chronic unpredictable stress (CUS) can cause behavioral and physiological abnormalities that are
important to the prediction of symptoms of depression that may be associated with cerebral glucose metabolic
abnormalities. Curcumin showed potential antidepressant effects, but whether or not it can reverse cerebral
functional abnormalities and so ameliorate depression remains unknown.
Methods: To investigate the effects of curcumin on brain activity in CUS rats, rats were subjected to 3 weeks of
CUS and then treated with curcumin orally at a dose of 40 mg/kg/day for one month. 18 F fluorodeoxyglucose
(18 F-FDG)-micro positron emission tomography (micro-PET) neuroimaging was used to detect changes in cerebral
metabolism. Body weight, sucrose preference, and open field tests were used to record depressive behaviors during
CUS and after curcumin treatment.
Results: Three weeks of CUS significantly decreased body weight, sucrose preference, sucrose consumption, total
distance travelling, and the number of rearing events. It also induced metabolic alterations in several parts of the
brain, showing increased glucose metabolism in the right hemisphere. After curcumin treatment for one month,
sucrose preference, sucrose consumption, total distance travelling, and the number of rearing events returned to
normal levels. Curcumin treatment also induced strong deactivation of the left primary auditory cortex and
activation of amygdalohippocampal cortex.
Conclusion: Curcumin was found to ameliorate the abnormalities in the behavior and brain glucose metabolism
caused by CUS, which may account for its antidepressive effects.Background
Depression is one of the most burdensome diseases in
the world [1]. It has been recognized as the alternation
of monoamine neurotransmitters serotonin and norepin-
ephrine in the brain [2]. Antidepressants that regulate
the monoamine neurotransmitter system have been used
successfully in clinical settings, but 20–30% of depressed
patients do not experience a satisfactory level of amelior-
ation [3]. For this reason, searching for an alternative
biological antidepressant that would be safer and more
effective is important. With the development of neuro-
imaging, many studies have depicted the limbic system* Correspondence: xuleizyey@126.com
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reproduction in any medium, provided the orin depression, showing changes in the structure and func-
tion of the prefrontal cortex, hippocampus, and amygdala
[4]. These neuropathologic alterations may mediate or re-
spond to the emotional, behavioral, and cognitive manifes-
tations of depressive episodes. For this reason, there are
reports of some antidepressants that ameliorate depres-
sion by reversing cerebral functional abnormalities [5].
Curcumin, a yellow plant pigment extracted from Curcuma
longa (turmeric) rhizomes, has wide-ranging neuroprotective
effects in the treatment of neuropsychiatric disorders, includ-
ing Parkinson’s disease, Alzheimer’s disease, schizophre-
nia, and epilepsy [6]. It is been reported that curcumin
can penetrate the blood–brain barrier and modulate the
levels of neurotransmitters like norepinephrine, dopamine,
and serotonin in the brain [3]. The antidepressive effects
of curcumin have been demonstrated in a variety of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suspension [9], olfactory bulbectomy model [10], and
chronic unpredicted stress (CUS) [11]. The mechanisms
by which curcumin counteracts depression might be asso-
ciated with several signaling pathways. For example, it is
probable that a monoamine oxidase inhibitor modulates
the serotonin and dopamine levels [7,8], blocks the release
of glutamate from rat prefrontal cortex nerve terminals
[12], increases the concentrations of brain-derived neuro-
trophic factor in the hippocampus and prefrontal cor-
tex, and promote neurogenesis [13]. Curcumin is also
believed to have an effect on diabetes mellitus by inhibiting
glucose uptake [14]. However, there is little informa-
tion regarding whether curcumin can reverse dysfunc-
tion of the cerebral glucose metabolism, which was
impaired in depression.
18 F fluorodeoxyglucose (18 F-FDG) is a high spatial
resolution tracer which can be used to perform animal
micro-PET imaging, which was used to investigate rat
brain activity during acute and chronic stress [15,16]. In
the present study, micro-PET imaging was performed to
investigate changes in behavior and brain glucose metab-
olism during depression after treatment with curcumin
in a CUS rat model, which is widely used to evaluate the
effects of antidepressants in vivo [17]. In the present
study, we want to use 18 F-FDG micro-PET imaging to
further explore the effects of curcumin on the behavioral
and brain glucose metabolism caused by CUS, which
will help to know the anti-depressive mechanism of
curcumin and promote its translational development.
Methods
Animal model
All experiments were performed in accordance with
the National Institutes of Health Guide for the Care
and Use of Laboratory Animals and they were approved
by the Committee on Animal Care and Usage of Zhejiang
University. A total of 27 male Sprague–Dawley rats with
body weights ranging from 280 to 300 g were obtained
from Shanghai Institutes for Biological Sciences. The rats
were housed in a humidity- and temperature-controlled
environment with 12-hour light/dark cycles and free ac-
cess to food and water. Prior to the experiments, the rats
were placed in a new environment for 7 days to allow
them to habituate to their housing conditions.
After one-week acclimation, a CUS model was established
as described previously in rats [18]. Control animals remained
in a comparable environment. Unpredictable stress in-
cluded water deprivation, empty water bottles, continuous
lighting, tilting of the cages, crowded housing, damp bed-
ding, white noise, and strobe lighting. These stress events
took place between 9:00 and 10:00 a.m. every day. The
specific experimental protocol is as stated in Table 1 and
all the experiments lasted for three weeks.Experimental design
Rats were randomly assigned into two groups: control
(n = 14) and CUS (n = 13). After 3-week stress stimula-
tion, CUS rats were further randomly divided into two
groups: model (n = 6) and treatment (n = 7). Curcumin
(purity ≥ 98%; Nanjing Zelang Medical Technological
Co.Ltd., China), was dissolved in rice bran oil to make a
40 mg/kg solution [11,19]. Starting from the second
month, the rats in the treatment group were given
curcumin by oral gavage. The model group was fed rice
bran oil. All experiments were performed in the morn-
ing from 9:00 to 11:00 a.m. The whole experimental pro-
cedure is shown in Figure 1.
Open field testing
The open-field test protocol was performed as described
in our earlier work [20]. Briefly, spontaneous activity
was measured and recorded for 5 min in an open field
to evaluate the difference between the groups. Briefly,
the test was conducted on white painted plywood
(72 cm × 72 cm) with walls 36 cm high in a soundproof
room with dim lighting. The rats had not undergone
previous habituation to this room. The base was divided
into 16 squares using white strips. These constituted the
peripheral and central sectors. Rats were initially placed
in the central sector and then released to explore the
facility for a 5 min period, during which the parame-
ters (e.g. total distance travelling, the number of rearing
events) were monitored using a VideoMot2–Video Activity
Measuring System (TSE systems GmbH, Germany).
Sucrose preference testing
The sucrose preference test procedure was performed as
previously described [21]. The rats were initially acclima-
tized to sucrose and water for three days. For the test,
rats were fed 5% sucrose solution (w/v) as follows: two
bottles of 5% sucrose solution were placed in each cage
for the first day; one bottle of water and one of sucrose
were placed in each cage on the second day, and the po-
sitions of the bottles were switched to eliminate the ef-
fects of side preference. On the third day, rats were
deprived of food and water for 24 h. On the fourth day,
rats were given one bottle of water and one bottle of
sucrose solution. Intakes of water and sucrose solution
were quantified by measurement of bottle volumes be-
fore and after the test. After 24 h, the volumes of su-
crose solution and water consumed were recorded, and
the sucrose preference was calculated using the follow-
ing formula: Sucrose preference = sucrose consumption/
(water consumption + sucrose consumption) × 100%.
Micro-PET scan
The micro-PET scan protocol was performed as described
in the previous study [15]. Before 18 F-FDG injection, the
Table 1 Chronic unpredictable stress (CUS) schedule
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
Water Deprivation 10:00→ 11:00
Empty Water Bottle 08:00→ 09:00
Continuous Lighting 10:00→ 8:00 17:00→ 10:00
Cage Tilt 11:00→ 17:00
Paired Housing → 8:00 10:00→ 10:00 10:00→ →
Damp Bedding 17:00→ 10:00
White Noise 10:00→ 13:00
Strobe Light 11:00→ 16:00 13:00→ 15:00
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order to enhance the uptake of the tracer by the brain and
to reduce the interference of other systems, like skeletal
muscle [22]. Each rat was placed on a heating pad which
was kept at 30°C for at least 30 min prior to 18 F-FDG in-
jection. Rats were briefly anesthetized using halothane gas
(1.5 min) in order to maximize tracer uptake by the brain.
The rats were then injected with approximately 18.5 MBq
(500 μCi) of 18 F-FDG through the tail vein either before
administration of curcumin or 0, 2, or 4 weeks after CUS.
After 40 min, the rats were placed in a spread-legged
prone position with halothane gas anesthesia (5% induc-
tion and 1.5% for maintenance) of micro PET R4 (Kyowa
micro Knoxville, TN, U.S.), which consists of a ring of 96
position-sensitive γ-ray scintillation detectors 15 cm in
diameter, providing a 10.8 cm trans-axial, and a 7.8 cm
axial field of view, with an intrinsic resolution < 1.8 mm.
The entire static process continued for 15 min.
Statistical analysis
Areas of the brain were manually extracted from all
micro-PET images. These images were normalized using
18 F-FDG rat brain templates. In order to obtain accurate
anatomical information, statistical parametric mapping
(SPM5) software for PET template normalization into
magnetic resonance imaging (MRI) template was used.Figure 1 Schedule of procedures used in the present study. Tests incluThis system was placed in stereotaxic space [23]. To in-
crease statistical power, all normalized images were
smoothed with an isotropic Gaussian kernel (2 mm full
width at half-maximum). Voxel-based statistical analyses
were carried out with the SPM5 software.
Because the data was not always normally distributed,
the difference between the groups was statistically evalu-
ated using nonparametric testing. Body weight was ana-
lyzed using a repeated measurement ANOVA (CUS and
control groups served as independent factors and time
served as a repeated measure). The effects of CUS on
sucrose preference, sucrose consumption, total distance
travelling, and the number of rearing events were an-
alyzed using the Mann–Whitney U-test. All behavioral
results were calculated using the median values. All
tests were two-tailed and the P values less than 0.05
were considered significant. Statistical analyses were
performed with SPSS version 18.0 (SPSS, Inc., Chicago,
IL, U.S.).
Results
Effects of CUS and curcumin on body weight and
behavior tests
A repeated measurement ANOVA (time × group as fac-
tors) revealed a main effect of time (F = 80.42, P < 0.05), a
main effect of group (F = 66.93, P < 0.05) and significantde the open field test, sucrose preference test, and micro-PET.
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CUS groups had similar body weights before the experi-
ments (P > 0.05). After 3 weeks of chronic stress stimula-
tion, the body weight gain in CUS group was significantly
slower than that of the control group. These differences
were found to be statistically significant (P < 0.05)
(Figure 2A).
In the sucrose preference test, control and CUS groups
showed comparable baseline sucrose preference andFigure 2 Behavioral indicators changed during the CUS procedure an
3 weeks of chronic unpredictable stress (CUS). ***P < 0.0001 shows the CUS
preference and sucrose consumption after 3 weeks of CUS and after 1 mon
vs. control group (n = 14). #P < 0.05 shows model group (n = 6) vs. control g
group (n = 6). (D) and (E) Open-field test indexes (total distance travelling
1 month of treatment. *P < 0.05, **P < 0.01 shows CUS group (n = 13) vs. co
group (n = 14). +P < 0.05 shows treatment group (n = 7) vs. model group (nsucrose consumption (data not shown). However, after
3 weeks of chronic stress, both sucrose preference and
sucrose consumption were significantly lower (5.5% and
6.7%) in the CUS group (Z = −2.706, P = 0.007. Figure 2B;
Z = −2.228, P = 0.026. Figure 2C) than in the control
group. One month later, the difference was further ampli-
fied to 8.7% and 18.6% (Z = −2.557, P = 0.011. Figure 2B;
Z = −2.148, P = 0.032. Figure 2C). However, treatment
with curcumin successfully reversed the effects of CUS,d after curcumin treatment. (A) Body weight changed during the
group (n = 13) vs. control group (n = 14). (B) and (C) Sucrose
th of treatment. *P < 0.05, **P < 0.01 shows the CUS group (n = 13)
roup (n = 14). +P < 0.05 shows treatment group (n = 7) vs. model
and the number of rearing events) after 3 weeks of CUS and after
ntrol group (n = 14). #P < 0.05 shows model group (n = 6) vs. control
= 6).
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and sucrose consumption than in the model group (11.7%
and 31.9%. Z = −2.429, P = 0.015. Figure 2B; Z = −2.286,
P = 0.022. Figure 2C).
There was no difference between groups with respect
to total activity during the 5 min open field test period
(data not shown) at the baseline. However, after 3 weeks,
CUS rats showed significantly less total distance travel-
ling (23.0%) and significantly fewer rearing events
(34.7%) than control rats (Z = −2.205, P = 0.027, Figure 2D;
Z = −2.717, P = 0.007, Figure 2E). After one month, model
rats also showed a significantly less total distance travelling
(20.7%) and significantly fewer rearing events (23.8%) than
control rats (Z = −2.062, P = 0.039. Figure 2D; Z = −2.072,
P = 0.038, Figure 2E). Curcumin treatment in CUS rats
was associated with significantly greater total distance trav-
elling (20.7%) and significantly more rearing events (56.3%)
than in the model group (Z = −2.143, P = 0.032. Figure 2D;
Z = −2.295, P = 0.022. Figure 2E).
Effects of CUS and curcumin on brain glucose metabolism
The differences in glucose metabolism in the coronal,
sagittal, and horizontal sections among control rats,
rats subjected to CUS, and CUS rats treated with
curcumin (40 mg/kg) are shown in Table 2. Using PaxinosTable 2 Parts of the brain showing changes in glucose metab
Groups Activation Regions
CUS vs. Control Increase Prim somatosens, upper li
Dorsolateral entorhinal co
Basilar artery
Decrease Mediodorsal thalami nu, c
Crus 2 of the ansiform lob
Crus 2 of the ansiform lob
Caudate putamen(striatum
Postsubiculum (L)
Cingulate cortex, area 1
Parietal cx,post area, rostra
Model vs. Control Increase Pyramidal decussation
Decrease Amygdalohip area, antero
Amygdalohip area, antero




Decrease Primary auditory cortex(L)
Spinal trigeminal nu, oral(
Pryamidal decussation
aPaxinos coordinates point to the location of the voxel with the t-value ( P < 0.05 focoordinates (ML, mediolateral; AP, anteroposterior; DV,
dorsoventral), CUS induced strong activation of the right
prim somatosens, right dorsolateral entorhinal cortex
and basilar artery, and strong deactivation of the left
mediodorsal thalami nuclear and cingulate cortex. One
month later, model rats showed significantly more deacti-
vation on both sides of the amygdalohippocampus
than control rats. The administration of curcumin
(40 mg/kg) induced strong activation of the left
amygdalohippocampus and significant deactivation in
the left primary auditory cortex.
Figure 3 summarizes these changes in several regions of
interest in the three groups. Figure 3A shows the changes
in glucose metabolism in coronal, sagittal, and horizontal
sections in model rats and in the control group. The
changes caused by curcumin comparing treatment group
to model group as shown in Figure 3B. Figure 3C shows the
administration of curcumin (40 mg/kg) inducing a strong
activation of the left amygdalohippocampus (AHiAL, L). In
contrast, significant deactivation was observed in the left pri-
mary auditory cortex (Au 1).
Discussion
In this study, 3-week CUS significantly decreased body
weight, sucrose preference, sucrose consumption, totalolism
Paxinos coordinatea T-value
ML AP DV
p(R) 6 −6 2 4.81
rtex(R) 8 −8 −4 3.96
0 −12 −12 3.28
entral(L) −1 −6 −3 −5.37
ule(L) −5 −6 −12 −5.08
ule(R) 3 −4 −13 −4.04
) (R) 3 −7 0 −4.35
−3 −3 −7 −3.62
0 −2 4 −3.36
l(R) 7 −2 −5 −3.23
0 −11 −16 2.7
lat(R) 4 −9 −4 −2.86
lat(L) −4 −9 −4 −2.31
(L) −3 −1 1 3.5
lat(L) −4 −9 −4 2.76
cx(R) 6 −6 −1 2.71
0 −1 −9 2
−6 −4 −5 −3.34
R) 3 −9 −11 −2.23
0 −11 −16 −2.01
r the rest) in the designated brain areas. L, left; R, right.
Figure 3 Glucose metabolism in the brain changed during the CUS procedure and after curcumin treatment. (A) Parts of the brain that
showed significant changes in glucose metabolism induced by chronic unpredictable stress (CUS) relative to the control group. (B) Changes
induced by CUS and the administration of curcumin compared with CUS group. (C) Changes in glucose metabolism in the brain. *Values differ
significantly between model and control groups, # Values differ significantly between treatment and model groups, according to Mann–Whitney
U (*P < 0.05 and #P < 0.05). Au1, primary auditory cortex (ML: -6.0 mm, AP: -4.0 mm, DV: -5.0 mm); AHiAL (L), left amygdalohippocampal area,
anterolateral part (ML: -4.0 mm, AP: -9.0 mm, DV: -4.0 mm); AHiAL(R), right amygdalohippocampal area, anterolateral part (ML: +4.0 mm, AP: -9
.0 mm, DV: -4.0 mm).
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It also induced metabolic alterations in several parts of
the brain, such as increased glucose metabolism in the
right hemisphere. After one month of curcumin treat-
ment, sucrose preference, sucrose consumption, total
distance travelling, and number of rearing events returned
to normal levels. These changes were associated with
stronger deactivation of the left primary auditory cortexand activation of the amygdalohippocampal cortex than
rats not given curcumin treatment. Overall, these data
showed that curcumin could improve the behavioral and
brain glucose metabolic abnormalities caused by CUS,
suggesting that curcumin might have an antidepressive
effect.
CUS was induced in male rats and their body weights
were recorded for 3 weeks. The open field test is a
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locomotor activity and willingness to explore in rodents
[24]. Open-field tests have shown a reduction in the
total distance travelling and the number of rearing
events in the CUS model, which can be considered indi-
cative of the severity of depressive symptoms [20]. Con-
sistent with a previous study [15], CUS rats here showed
a decrease in sucrose consumption and sucrose prefer-
ence, which is generally considered an indication of
anhedonia [25]. The sucrose preference test is an object-
ive behavioral indicator in rodent CUS model [26]. Here,
this test showed that, after CUS, the rewarding value of
sucrose solution was disrupted. Combined with the sig-
nificant weight loss observed after CUS, these data indi-
cate that the CUS model was effective.
The changes in the behavior in CUS rats were accom-
panied by alterations in glucose metabolism, specifically,
increased glucose metabolism in the right prim somatosens,
right dorsolateral entorhinal cortex, and basilar artery and
decreased metabolism in the left mediodorsal thalami nu-
clear and cingulate cortex. In human beings, the right
hemisphere is primarily responsible for dealing with nega-
tive emotions and the formation of pessimistic thinking.
The left hemisphere is primarily responsible for processing
pleasant experiences, and the relative decay can lead
to anhedonia [27]. In neuroimaging studies, unipolar
depressed patients show hypoactivity in the left hemi-
sphere and hyperactivity in the right hemisphere [28,29].
The severity of depression has been shown to be positively
correlated with right hemisphere hyperactivity [28]. In
these ways, the abnormalities in glucose metabolism here
observed in the CUS depression model was consistent
with what has been observed in depressed patients,
suggesting that this widely used animal model could also
be used for further study of alterations in brain activity in
depression.
One month of curcumin treatment significantly
counteracted the decrease in four parameters, sucrose
preference, sucrose consumption, total distance travel-
ling, and number of rearing events. This suggests that
curcumin might have a mild antidepressive effect.
After one month of curcumin treatment at 40 mg/kg,
the discrepancy in glucose metabolism between CUS
and control groups was diminished. Nevertheless, sev-
eral new parts of the brain showed significant differ-
ences, mainly gathered at amygdalohippocampus and
left primary auditory cortex. It might be due to an exten-
sion of the CUS effect, primarily non-responsive parts of
the brain start reacting to stress as time goes on.
Both sides of the amygdalohippocampus showed signifi-
cantly more deactivation in the model rats than control
rats, while the treatment of curcumin played a role in re-
sistance to such changes in the present study. In previous
studies, patients with major depressive disorders showedabnormal activation in the amygdala when presented with
emotional stimuli [30]. These data indicated that the
amygdala is involved in the etiopathology of depression
and that curcumin might improve emotional processing.
The serotonin hypothesis states that serotonin might be
an important explanation for the present observed results.
It has been reported that curcumin strongly increased
the serotonin levels and inhibited monoamine oxidase
in mice [5]. One report has suggested that acute sero-
tonin reuptake blockage may affect human amygdala
reactivity [31]. In this way, the activation of glucose
metabolism in the amygdalohippocampus might con-
tribute to an increase in serotonin caused by curcumin.
The amygdalohippocampus, a part of the cortical-amygdal
loop, is involved in emotional processing. Previous studies
have shown that the amygdalohippocampal area receives
dense serotonergic input [24,25]. The serotonin hypoth-
esis of depression suggests that levels of serotonin metab-
olites are low in depressed individuals and that levels of
central serotonin are low in the brains of suicide victims
[25]. The CUS model also suggests a decrease in serotonin
metabolites in the frontal cortex, striatum, and hippocam-
pus [26]. Confusingly, previous studies have demonstrated
that the resting cerebral blood flow and glucose metabol-
ism are abnormally elevated in the amygdala in patients
with major depressive disorder but not in patients with
unipolar depression [32]. These data seem to conflict with
the present results, but three major factors might explain
this contradiction. There are profound differences be-
tween different species difference, such as human beings
and rodents. There is also a dearth of effective research
that illustrates whether emotional processing is consistent
across these different species. Another possibility is that,
in the present study, the amygdalohippocampus, the cau-
dal third of the amygdala which abuts the hippocampal
formation, but not the whole amygdala, showed significant
deactivation in model rats. It is possible that different
parts of the amygdala have diverse responses to CUS and
curcumin, but further research is needed to confirm these
conclusions. It should be noted that the amygdala does
not show over-activation in patients with unipolar depres-
sion [32], which indicates that abnormally elevation of
amygdala may be associated with the manic phase. Previ-
ous studies have shown that stimulating the amygdala
caused the animal to become more active and to attempt
to escape the stimulation, indicating defensive behaviors
[33]. Further investigation is needed to address these
questions.
Conversely, the auditory cortex showed a significant
deactivation after curcumin treatment. The auditory cor-
tex is closely related to the amygdalohippocampus and is
also rich in serotonergic fibers. The excitability of the
auditory cortex is assumed to be under serotonergic
control. Decreases and increases in serotonin function
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ability, respectively [34]. Consistent with this suggestion,
the present results showed that curcumin may act as a
monoamine oxidase inhibitor can increase the serotonin
levels, which cause the deactivation of the auditory cortex.
Curcumin, which has multiple bioactivities, also functions
as a potent inhibitor of neuronal cell death in response to
oxidative stress in auditory neurons [35]. However, the
exact mechanism by which curcumin affects cerebral glu-
cose metabolism requires further investigation.
Previous functional neuroimaging studies using 133Xe
blood flow, single photon emission computed tomog-
raphy (SPECT), and PET have consistently demonstrated
decreased regional cerebral blood flow (rCBF) or metab-
olism in the frontal lobe [36], temporal lobe [37], or anter-
ior cingulate gyrus [38] of depressed patients. Our results
also demonstrated that curcumin can alleviate CUS
induced stress through improving cerebral glucose metab-
olism. Although it is still lack of clinical test, the antidepres-
sant effect of curcumin has been proved by availability of
vast preclinical evidence [6], implying curcumin can allevi-
ate the symptoms of depression by various mechanisms,
such as inhibiting monoamine oxidase enzyme, modulating
the level of various neurotransmitters, and promoting hip-
pocampal neurogenesis [6]. Thus, based on these studies, it
will be helpful for curcumin or related agents translational
development in the future.
However, there are some limitations in the present
study. First, micro PET technology itself has certain lim-
itations. This may bias the statistical analysis when rela-
tively large parts of the brain are involved, so the present
study only measured changes in glucose metabolism in
small parts of the brain rather than in the hippocampus
or prefrontal cortex. Second, the present study involved
a small sample size. Finally, the biggest limitation of the
current study is not clearly specified on hypothesis by
which mechanism curcumin affects cerebral glucose me-
tabolism. According to the present results, our future
research will aim to test the hypothesis of curcumin
against depression by inhibiting monoamine oxidase in a
large sample.
Conclusions
In summary, CUS induced weight loss and depression or
anxiety behaviors in rats. These changes were accom-
panied by metabolic alterations in several parts of the
brain regions, specifically increased glucose metabolism
in the right hemisphere. Curcumin treatment reversed
these depression and anxiety behaviors and induced
strong deactivation of the left primary auditory cortex
and activation of amygdalohippocampal cortex. These
data suggest that curcumin may act as an antidepressive
agent, possibly by reversing the abnormal brain glucose
metabolism that occurs in depressed organisms.Competing interests
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